Abstract
Comparison of outcomes between psoriasis (Ps) patients (Pts) who switched from etanercept (ETA) to adalimumab (ADA) versus to ustekinumab (UST)
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
